Abiopharma

🔍 JORE MATTHEW B (Executive)

Company: AirJoule Technologies Corp. (AIRJ)

Report Date: 2026-06-05

Detailed Transactions and Holdings:

• Acquired 12,500 shares of Class A Common Stock (Direct)
  Date: 2026-06-05 | Code: M | equity_swap_involved: false | shares_owned_after: 7,751,749.00 | transaction_form_type: 4
• Sold 3,729 shares of Class A Common Stock at $4.87 per share (Direct)
  Date: 2026-06-05 | Code: F | equity_swap_involved: false | shares_owned_after: 7,748,020.00 | transaction_form_type: 4
• Sold 12,500 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-05 | Code: M | equity_swap_involved: false | shares_owned_after: 25,000.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: The restricted stock units vest in four equal annual installments beginning on June 6, 2025. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock.